Clinical Trials Logo

Clinical Trial Summary

The Phase 1 component of the study is a double-blind, placebo-controlled, single ascending dose (SAD) design intended to assess the safety, tolerability, and PK of CBL-514. The SAD part will involve 9 proposed dosing cohorts.


Clinical Trial Description

The Phase 1 part of the study was a first-in-human, single ascending dose, double-blind, randomized (except Cohorts 6 to 9 [open-label]) study in healthy subjects to evaluate the safety, tolerability and PK of CBL-514, and to determine the dose levels to be used for the Phase 2a part of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04699669
Study type Interventional
Source Caliway Biopharmaceuticals Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date November 27, 2018
Completion date August 20, 2019

See also
  Status Clinical Trial Phase
Completed NCT02512822 - Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring N/A
Recruiting NCT06005441 - A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. Phase 2
Active, not recruiting NCT05736107 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat Phase 2
Not yet recruiting NCT03160976 - Cryolipolysis on Localized Adiposity N/A
Completed NCT03871556 - Diagnostic Ultrasound for Measuring Fat of the Body N/A
Completed NCT02098811 - Evaluation of the Safety and Precursors of Efficacy N/A
Active, not recruiting NCT04553627 - Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis N/A
Completed NCT02539043 - Effects of Ultrasound Cavitation Focused on Located Adiposity N/A
Completed NCT01842802 - Clinical Investigation of Non Invasive Fat Reduction N/A
Completed NCT04698642 - A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat Phase 2
Completed NCT02052622 - Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Phase 3
Completed NCT04897412 - A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) Phase 2
Completed NCT03682471 - Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
Completed NCT05234736 - A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers Phase 2
Completed NCT04575467 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) Phase 2